BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asano T, Nakamura H, Uehara Y, Yamamoto Y. Design, synthesis, and biological evaluation of aminoboronic acids as growth-factor receptor inhibitors of EGFR and VEGFR-1 tyrosine kinases. Chembiochem. 2004;5:483-490. [PMID: 15185372 DOI: 10.1002/cbic.200300748] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hiller NJ, Silva NAAE, Faria RX, Souza ALA, Resende JALC, Borges Farias A, Correia Romeiro N, de Luna Martins D. Synthesis and Evaluation of the Anticancer and Trypanocidal Activities of Boronic Tyrphostins. ChemMedChem 2018;13:1395-404. [PMID: 29856519 DOI: 10.1002/cmdc.201800206] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
2 Couto M, Mastandrea I, Cabrera M, Cabral P, Teixidor F, Cerecetto H, Viñas C. Small-Molecule Kinase-Inhibitors-Loaded Boron Cluster as Hybrid Agents for Glioma-Cell-Targeting Therapy. Chemistry 2017;23:9233-8. [PMID: 28605114 DOI: 10.1002/chem.201701965] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
3 Nakamura H, Kuroda H, Saito H, Suzuki R, Yamori T, Maruyama K, Haga T. Synthesis and biological evaluation of boronic acid containing cis-stilbenes as apoptotic tubulin polymerization inhibitors. ChemMedChem 2006;1:729-40. [PMID: 16902927 DOI: 10.1002/cmdc.200600068] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
4 Zhong Y, Wu Y, Liu R, Li Z, Chen Y, Evans T, Chuang P, Das B, He JC. Novel retinoic acid receptor alpha agonists for treatment of kidney disease. PLoS One 2011;6:e27945. [PMID: 22125642 DOI: 10.1371/journal.pone.0027945] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
5 Takahashi K, Nakamura H, Furumoto S, Yamamoto K, Fukuda H, Matsumura A, Yamamoto Y. Synthesis and in vivo biodistribution of BPA-Gd-DTPA complex as a potential MRI contrast carrier for neutron capture therapy. Bioorg Med Chem 2005;13:735-43. [PMID: 15653341 DOI: 10.1016/j.bmc.2004.10.046] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
6 Levonis SM, Kiefel MJ, Houston TA. Boronolectin with divergent fluorescent response specific for free sialic acid. Chem Commun 2009. [DOI: 10.1039/b900836p] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
7 Nakamura H, Sasaki Y, Uno M, Yoshikawa T, Asano T, Ban HS, Fukazawa H, Shibuya M, Uehara Y. Synthesis and biological evaluation of benzamides and benzamidines as selective inhibitors of VEGFR tyrosine kinases. Bioorganic & Medicinal Chemistry Letters 2006;16:5127-31. [DOI: 10.1016/j.bmcl.2006.07.075] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
8 Piergies N, Proniewicz E, Kudelski A, Rydzewska A, Kim Y, Andrzejak M, Proniewicz LM. Fourier Transform Infrared and Raman and Surface-Enhanced Raman Spectroscopy Studies of a Novel Group of Boron Analogues of Aminophosphonic Acids. J Phys Chem A 2012;116:10004-14. [DOI: 10.1021/jp307064p] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
9 Smoum R, Rubinstein A, Dembitsky VM, Srebnik M. Boron containing compounds as protease inhibitors. Chem Rev 2012;112:4156-220. [PMID: 22519511 DOI: 10.1021/cr608202m] [Cited by in Crossref: 231] [Cited by in F6Publishing: 128] [Article Influence: 25.7] [Reference Citation Analysis]
10 Piergies N, Proniewicz E, Kim Y, Proniewicz LM. Interaction of N -benzylamino(boronphenyl)methylphosphonic acid analogs with the gold colloidal surface under different concentration and pH conditions: Interaction of N -benzylamino(boronphenyl)methylphosphonic acid analogs. J Raman Spectrosc 2014;45:581-90. [DOI: 10.1002/jrs.4505] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
11 Baker SJ, Tomsho JW, Benkovic SJ. Boron-containing inhibitors of synthetases. Chem Soc Rev 2011;40:4279. [DOI: 10.1039/c0cs00131g] [Cited by in Crossref: 170] [Cited by in F6Publishing: 95] [Article Influence: 17.0] [Reference Citation Analysis]
12 Ban HS, Nakamura H. Boron-Based Drug Design: Boron-Based Drug Design. The Chemical Record 2015;15:616-35. [DOI: 10.1002/tcr.201402100] [Cited by in Crossref: 80] [Cited by in F6Publishing: 38] [Article Influence: 13.3] [Reference Citation Analysis]
13 Hosoya T, Yamamoto Y, Uehara Y, Hayashi M, Komiyama K, Ishibashi M. New cytotoxic bisindole alkaloids with protein tyrosine kinase inhibitory activity from a myxomycete Lycogala epidendrum. Bioorganic & Medicinal Chemistry Letters 2005;15:2776-80. [DOI: 10.1016/j.bmcl.2005.03.103] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
14 Asano T, Yoshikawa T, Usui T, Yamamoto H, Yamamoto Y, Uehara Y, Nakamura H. Benzamides and benzamidines as specific inhibitors of epidermal growth factor receptor and v-Src protein tyrosine kinases. Bioorganic & Medicinal Chemistry 2004;12:3529-42. [DOI: 10.1016/j.bmc.2004.04.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
15 Faria RX, de Jesus Hiller N, Salles JP, Resende JALC, Diogo RT, von Ranke NL, Bello ML, Rodrigues CR, Castro HC, de Luna Martins D. Arylboronic acids inhibit P2X7 receptor function and the acute inflammatory response. J Bioenerg Biomembr 2019;51:277-90. [PMID: 31256283 DOI: 10.1007/s10863-019-09802-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
16 Molander GA, Cooper DJ. Functionalization of organotrifluoroborates: reductive amination. J Org Chem 2008;73:3885-91. [PMID: 18412389 DOI: 10.1021/jo800383e] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
17 Shimizu K, Maruyama M, Yasui Y, Minegishi H, Ban HS, Nakamura H. Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1alpha inhibitors. Bioorg Med Chem Lett 2010;20:1453-6. [PMID: 20083404 DOI: 10.1016/j.bmcl.2009.12.037] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
18 Proniewicz E, Piergies N, Ozaki Y, Kim Y, Proniewicz LM. Investigation of adsorption mode of a novel group of N-benzylamino(boronphenyl)methylphosphonic acids using SERS. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2013;103:167-72. [DOI: 10.1016/j.saa.2012.10.040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
19 Deng J, Dayam R, Neamati N. Patented small molecule inhibitors of p53–MDM2 interaction. Expert Opinion on Therapeutic Patents 2006;16:165-88. [DOI: 10.1517/13543776.16.2.165] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
20 Minegishi H, Matsukawa T, Nakamura H. Synthesis and Biological Evaluation of Diaryl-Substituted Carboranes as Inhibitors of Hypoxia Inducible Factor (HIF)-1 Transcriptional Activity. ChemMedChem 2013;8:265-71. [DOI: 10.1002/cmdc.201200502] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
21 Piergies N, Proniewicz E, Ozaki Y, Kim Y, Proniewicz LM. Influence of Substituent Type and Position on the Adsorption Mechanism of Phenylboronic Acids: Infrared, Raman, and Surface-Enhanced Raman Spectroscopy Studies. J Phys Chem A 2013;117:5693-705. [DOI: 10.1021/jp404184x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
22 Tomsho JW, Benkovic SJ. Elucidation of the Mechanism of the Reaction between Phenylboronic Acid and a Model Diol, Alizarin Red S. J Org Chem 2012;77:2098-106. [DOI: 10.1021/jo202250d] [Cited by in Crossref: 62] [Cited by in F6Publishing: 36] [Article Influence: 6.9] [Reference Citation Analysis]